[ 1 ] Krishnan E, Pandya BJ, Chung L, et al. Hyperuricemia and the risk for subclinical coronary atherosclerosis: data from a prospective observational cohort study[J]. Arthritis Res Ther, 2011, 13(2): R66.
[2]
[ 2 ] Barron HV, Harr SD, Radford MJ, et al. The association between white blood cell count and acute myocardial infarction mortality in patients >or = 65 years of age: findings from the cooperative cardiovascular project[J]. J Am Coll Cardiol, 2001, 38(6): 1654-1661.
[3]
[ 3 ] Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction[J]. Eur Heart J, 2007, 28(20): 2525-2538.
[4]
[ 4 ] Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal definition of myocardial infarction[J]. Eur Heart J, 2012, 33(20): 2551-2567.
[ 6 ] van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology[J]. Circulation, 1994, 89(1): 36-44.
[7]
[ 7 ] Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes[J]. Circulation, 2002, 106(23): 2894-2900.
[8]
[ 8 ] Kojima S, Sakamoto T, Ishihara M, et al. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era[J]. Ann Med, 2004, 36(2): 153-160.
[9]
[ 9 ] Ishihara M, Inoue I, Kawagoe T, et al. Impact of prodromal angina pectoris and white blood cell count on outcome of patients with acute myocardial infarction[J]. Int J Cardiol, 2005, 103(2): 150-155.
[10]
Rohani A, Akbari V, Moradian K, et al. Combining white blood cell count and thrombosis for predicting in-hospital outcomes after acute myocardial infraction[J]. J Emerg Trauma Shock, 2011, 4(3): 351-354.
[11]
Avramakis G, Papadimitraki E, Papakonstandinou D, et al. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina[J]. Platelets, 2007, 18(1): 16-23.
[12]
Botto N, Sbrana S, Trianni G, et al. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for “no-reflow” phenomenon[J]. Int J Cardiol, 2007, 117(1): 123-130.
[13]
Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis[J]. Arthritis Care Res (Hoboken), 2010, 62(2): 170-180.
[14]
Coutinho Tde A, Turner ST, Peyser PA, et al. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis[J]. Am J Hypertens, 2007, 20(1): 83-89.
Ho WJ, Tsai WP, Yu KH, et al. Association between endothelial dysfunction and hyperuricaemia[J]. Rheumatology, 2010, 49(10): 1929-1934.
[17]
Kuwahata S, Hamasaki S, Ishida S, et al. Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA[J]. J Atheroscler Thromb, 2010, 17(3): 259-269.
